Terug
54
Dagbereik
€ 86,15
€ 87,95
52-Weeksbereik
€ 84,59
€ 114,44
Volume
1.737.987
50D / 200D Gem.
€ 92,18
/
€ 95,23
Vorige Slotkoers
€ 86,32
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 24,6 | 0,2 |
| P/B | 1,4 | 3,0 |
| ROE % | 5,6 | 3,6 |
| Net Margin % | 8,6 | 3,8 |
| Rev Growth 5Y % | 4,8 | 9,9 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 105,60
+20.5%
Low: € 89,00
High: € 122,00
Forward K/W
10,44
Forward WPA
€ 8,40
WPA Groei (sch.)
+0,0%
Omzet Sch.
8,55B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 10,91
€ 10,61 – € 11,13
|
10,20B | 2 |
| FY2029 |
€ 10,34
€ 10,06 – € 10,55
|
9,69B | 2 |
| FY2028 |
€ 9,54
€ 7,04 – € 11,01
|
9,19B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | € 2,40 | € 2,42 | +0,8% |
| 2025-11-05 | € 1,87 | € 1,90 | +1,6% |
| 2025-08-07 | € 1,98 | € 2,07 | +4,5% |
| 2025-05-05 | € 1,77 | € 1,81 | +2,3% |
| 2025-02-06 | € 2,30 | € 2,31 | +0,4% |
| 2024-10-30 | € 1,74 | € 1,74 | 0,0% |
| 2024-08-07 | € 1,99 | € 2,01 | +1,0% |
| 2024-05-02 | € 1,87 | € 1,94 | +3,7% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,27%
Growth (3Y)
0,00%
Growth (5Y)
0,00%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 30, 2026 | € 0,24 | 1,10% |
| Dec 30, 2025 | Jan 30, 2026 | € 0,24 | 1,06% |
| Sep 30, 2025 | Oct 31, 2025 | € 0,24 | 0,97% |
| Jun 26, 2025 | Jul 31, 2025 | € 0,24 | 1,05% |
| Mar 31, 2025 | Apr 30, 2025 | € 0,24 | 0,85% |
| Dec 30, 2024 | Jan 31, 2025 | € 0,24 | 0,91% |
| Sep 30, 2024 | Oct 31, 2024 | € 0,24 | 0,89% |
| Jun 26, 2024 | Jul 31, 2024 | € 0,24 | 0,89% |
| Mar 27, 2024 | Apr 30, 2024 | € 0,24 | 0,72% |
| Dec 26, 2023 | Jan 31, 2024 | € 0,24 | 0,79% |
| Sep 28, 2023 | Oct 31, 2023 | € 0,24 | 0,85% |
| Jun 23, 2023 | Jul 31, 2023 | € 0,24 | 0,67% |
| Mar 28, 2023 | Apr 28, 2023 | € 0,24 | 0,76% |
| Dec 23, 2022 | Jan 31, 2023 | € 0,24 | 0,76% |
| Sep 29, 2022 | Oct 31, 2022 | € 0,24 | 0,89% |
| Jun 24, 2022 | Jul 29, 2022 | € 0,24 | 0,87% |
| Mar 28, 2022 | Apr 29, 2022 | € 0,24 | 0,75% |
| Dec 27, 2021 | Jan 31, 2022 | € 0,24 | 0,75% |
| Sep 29, 2021 | Oct 29, 2021 | € 0,24 | 0,64% |
| Jun 25, 2021 | Jul 30, 2021 | € 0,24 | 0,58% |
Belangrijkste Punten
Revenue grew 4,79% annually over 5 years — modest growth
Earnings declined -21,97% over the past year
Generating 1,47B in free cash flow
Cash machine — converts 208,81% of earnings into free cash flow
Capital efficient — spends only 2,73% of revenue on capex
Groei
Revenue Growth (5Y)
4,79%
Revenue (1Y)7,20%
Earnings (1Y)-21,97%
FCF Growth (3Y)11,37%
Kwaliteit
Return on Equity
5,60%
ROIC5,05%
Net Margin8,57%
Op. Margin16,55%
Veiligheid
Debt / Equity
0,59
Current Ratio1,98
Interest Coverage4,65
Waardering
P/E Ratio
24,63
Forward P/E10,44
P/B Ratio1,37
EV/EBITDA17,84
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,20% | Revenue Growth (3Y) | 5,51% |
| Earnings Growth (1Y) | -21,97% | Earnings Growth (3Y) | -17,01% |
| Revenue Growth (5Y) | 4,79% | Earnings Growth (5Y) | 15,11% |
| Profitability | |||
| Revenue (TTM) | 8,23B | Net Income (TTM) | 705,20M |
| ROE | 5,60% | ROA | 3,05% |
| Gross Margin | 61,62% | Operating Margin | 16,55% |
| Net Margin | 8,57% | Free Cash Flow (TTM) | 1,47B |
| ROIC | 5,05% | FCF Growth (3Y) | 11,37% |
| Safety | |||
| Debt / Equity | 0,59 | Current Ratio | 1,98 |
| Interest Coverage | 4,65 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,27% |
| Dividend Growth (3Y) | 0,00% | Dividend Growth (5Y) | 0,00% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 24,63 | Forward P/E | 10,44 |
| P/B Ratio | 1,37 | P/S Ratio | 2,11 |
| PEG Ratio | -1,26 | Forward PEG | N/A |
| EV/EBITDA | 17,84 | Fwd EV/EBITDA | 10,77 |
| Forward P/S | 2,03 | Fwd Earnings Yield | 9,58% |
| FCF Yield | 8,48% | ||
| Market Cap | 17,37B | Enterprise Value | 24,30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8,23B | 7,68B | 7,39B | 6,94B | 6,83B |
| Net Income | 705,20M | 903,80M | 1,02B | 231,40M | 401,60M |
| EPS (Diluted) | 3,55 | 4,43 | 4,88 | 1,10 | 1,91 |
| Gross Profit | 5,07B | 5,49B | 5,31B | 4,92B | 4,87B |
| Operating Income | 1,36B | 1,29B | 1,28B | 696,30M | 860,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 23,09B | 21,37B | 21,50B | 21,07B | 23,46B |
| Total Liabilities | 10,39B | 8,89B | 9,01B | 9,04B | 10,79B |
| Shareholders' Equity | 12,71B | 12,47B | 12,48B | 12,02B | 12,66B |
| Total Debt | 7,52B | 6,20B | 5,77B | 5,70B | 7,07B |
| Cash & Equivalents | 591,90M | 525,50M | 415,80M | 375,70M | 378,10M |
| Current Assets | 5,12B | 4,67B | 4,61B | 4,43B | 4,89B |
| Current Liabilities | 2,58B | 2,45B | 2,86B | 2,36B | 3,47B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#337 of 1049
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026